• Skip to main content
  • Skip to secondary menu
  • Skip to footer

OPINT

OPINT stands for Operational Intelligence

  • About
    • GDPR
  • Sponsored Post
    • Make a Contribution
  • Job Board
  • Contact

Avellino Surpasses Two Million COVID-19 Tests in United States

June 28, 2021 By admin Leave a Comment

Company’s SARS-CoV-2/COVID-19 Test (AvellinoCoV2) – One of the First COVID-19 Tests to Receive EUA – Continues to Play Critical Role in Public Health Efforts

MENLO PARK, Calif. – Avellino Lab USA, Inc. (Avellino) today announced that more than two million of its SARS-CoV-2/COVID-19 tests (AvellinoCoV2) have now been performed in the United States.

Avellino was one of the first private companies in the U.S. to receive an Emergency Use Authorization (EUA) from the FDA for AvellinoCoV2 in March 2020. The test provided much-needed testing capacity during the initial surge of the pandemic in the U.S., in particular among populations in skilled nursing facilities, schools, colleges and government municipalities.

The AvellinoCoV2 test targets the N-gene region of the SARS-CoV-2 virus, which has so far proven to be less prone to mutations seen in COVID-19 variants, helping to prevent false negatives that can occur when targeting areas of the virus that are more susceptible to mutations.

Further supporting local and national public health efforts, Avellino received an EUA in November 2020 for its COVID-19/Flu AvellinoCoV2 Respiratory test, which is designed to differentiate between COVID-19 and the various types of influenza viruses.

For both the AvellinoCoV2 and AvellinoCoV2-Respiratory tests, Avellino processes the tests in the company’s high complexity CLIA-certified lab. The lab can process tens of thousands of tests a day, with further plans to continually increase capacity. This focus on increased capacity helped enable Avellino to quickly respond to the pandemic.

“Just prior to COVID-19, we had begun a limited rollout of our first genetic eye test, AvaGen; however, with the onset of COVID-19, we were able to apply our complex genetic expertise to focus on a novel molecular viral test, navigate the regulatory pathway, modify our CLIA-certified lab and scale rapidly,” said Avellino CEO Jim Mazzo.

He continued, “We have since resumed the launch of our genetic eye test; however, we recognize that COVID-19 may be with us for the long-term, and our respiratory portfolio remains needed and valuable. With SARS-CoV-2 continuing to mutate and respiratory infections prevalent every fall, no one knows how COVID-19 may continue to affect us in the future. What we do know is that we have a talented and nimble team that has demonstrated they are up for the toughest challenges in health.”

Avellino possesses genome sequencing capabilities, which can help in the efforts to track the spread of emerging SARS-CoV-2 variants. Data from this sequencing is reported to the CDC as part of its SPHERES program (SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance), which is aimed at coordinating sequencing efforts nationally in support of larger COVID-19 mitigation efforts.

About Avellino
Avellino Lab USA, Inc. is a global leader in gene therapy and molecular diagnostics at the forefront of precision medicine for eye care. With a long-term mission to develop personalized approaches to improve health and disease management through genomics, the company is developing a transformative genetic diagnostics product pipeline, as well as genetic therapeutics leveraging CRISPR gene editing, to better manage, and potentially cure, inherited diseases. The company also developed the Avellino SARS-CoV-2 RT-PCR diagnostic test to aid in COVID-19 pandemic testing efforts in the US, and was the third private company in the nation to receive EUA for its COVID-19 test. Avellino is headquartered in Silicon Valley, California, with operations in Korea, Japan, China and the UK.

To learn more about Avellino, visit www.avellino.com.

Filed Under: News Tagged With: COVID-19, biotech

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • Cybersecurity Digest: Law Lapses, Cisco Flaws, Ransomware Surge
  • PhotoX Advanced Sciences 2025, September 22–24, Austin, Texas
  • “Buy” Recommendation: Cloudflare Positioned for Sustained Growth and Profitability
  • Navigating the Expanding World of Cybersecurity with CybersecurityMarket.com
  • A New Front Opens: North Korea Joins Russia’s War Effort
  • South Korea’s Innovation Showcase: 24 Startups Take Center Stage at TechCrunch Disrupt 2024
  • Spain’s Digital Nomad Visa: A Gateway to a Work-Life Adventure in the Sun
  • Smartoptics enters long-term partnership with US technology solutions provider WIN Technology
  • The Ever-Present Challenge: Why Cybersecurity Remains a Critical Concern
  • European Shoppers Cut Spending Despite Easing Inflation, BCG Survey Finds

Media Partners

  • Cybersecurity Market
  • Media Partners
YugabyteDB’s Distributed SQL Summit (DSS 2025), November 10, 2025, Atlanta, Georgia
Qantas Data Breach: Millions of Customers Exposed in Dark Web Leak
Netskope’s Nasdaq Debut: A Strong Signal for Cybersecurity Growth
BreachLock Named Sample Vendor for PTaaS and AEV in Two New 2025 Gartner® Reports
Modirum Platforms Expands to the U.S., Strengthening Critical Infrastructure Security
Is Zscaler’s Moat Wide Enough to Hold Off Competition?
Epiq Expands Global Cyber Response Capabilities with Acquisition of First Watch Data Breach Solutions
Upcoming Cybersecurity Events to Watch in 2025
Axonius CTRL/ACT, October 22–23, 2025, Virtual
Cloudflare and Giga Unite to Bridge the Global School Connectivity Divide
DN4B
OSINT
Dossier
Travel MKTG
Bootstrapping
Renewability
Cyber Security Market
Abbreviatory
API Coding
Side Hustle Art

Media Partners

  • Defense Market
  • Media Partners
United Launch Alliance Successfully Launches 100th National Security Mission
Farnborough International Airshow 2024: Registration Now Open
V2X Secures $103 Million Contract for U.S. Navy C-26 Aircraft Maintenance
CACI to acquire Azure Summit Technology for $1.275 billion
HELI EXPO 2023 is set to take place from March 6-9, 2023, at the Georgia World Congress Center in Atlanta, Georgia
Counter UAS Technology Europe 2024: Echodyne to Address Key C-UAS Conference Amidst Rapid Expansion into European Market
L3Harris Receives VAMPIRE Contract for Ukrainian Security Defense Efforts
IDEX 2023, NAVDEX 2023, and the accompanying International Defence Conference (IDC) will be held from 20-24 February 2023 at the Abu Dhabi National Centre
EDGE Signs Historic $2.45 Billion Naval Contract with Kuwait
Electra Awarded $20 Million from U.S. Department of Defense Under the Defense Production Act
DN4B
Policymaker
API Coding
OSINT
S3H
Photo Contest
ESN
Passerby
VPNW
Defense Market

Copyright © 2022 OPINT.com